Aquestive Therapeutics Inc

NASDAQ:AQST   1:00:00 PM EDT
3.72
+0.04 (+1.09%)
4:59:11 PM EDT: $3.75 +0.03 (+0.81%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)369.51M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$11.32 Million
Adjusted EPS-$0.17
See more estimates
10-Day MA$3.44
50-Day MA$2.99
200-Day MA$3.60
See more pivots

Aquestive Therapeutics Inc Stock, NASDAQ:AQST

30 Technology Drive, Warren, New Jersey 07059
United States of America
Phone: +1.908.941.1900
Number of Employees: 142

Description

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients� therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.